EKSO: Ekso Bionics Holdings, Inc. Common Stock Company Profile & Statistics

About

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California.

Info & Links

CEO

Scott G. Davis

Headquarters

101 GLACIER POINT, SUITE A
SAN RAFAEL, CA 94901, UNITED STATES

Auditor

WithumSmith+Brown, PC

Share holders

175

Employees

Ekso Bionics Holdings, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

12.12M

Enterprise Value

9.19M

Enterprise Value/EBITDA(ttm)

-0.92

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.70

Price to Book(mrq)

0.83

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

51.90%

Operating Margin(ttm)

-62.95%

Profit Margin(ttm)

-64.15%

Return on Equity(ttm)

-83.09%

Return on Invested Capital(ttm)

-62.46%

Return on Assets(ttm)

-39.03%

Income Statement

Revenue(ttm)

17.68M

Revenue Per Share(ttm)

0.80

Gross Profit(ttm)

9.17M

EBITDA(ttm)³

-10.04M

Net Income Available to Common(ttm)

-11.13M

Diluted EPS(ttm)

-0.65

Share Statistics

Beta (5Y Monthly)

1.46

52-Week Change

-69.20%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

22.00M

Dividend Yield

0.00%

Float⁴

20.66M

% Held by Insiders

6.10%

% Held by Institutions

6.42%

Balance Sheet

Total Cash(mrq)

8.29M

Total Cash Per Share(mrq)

0.38

Total Debt(mrq)

5.36M

Total Debt/Equity(mrq)

36.02%

Current Ratio(mrq)

2.81%

Quick Ratio(mrq)

2.14%

Book Value Per Share(mrq)

0.68

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.41

Free Cash Flow(ytd)

-8.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

EKSO

Ekso Bionics Holdings, Inc. Common Stock

Ekso Bionics Holdings, Inc. Common Stock Profile